Canada markets closed

Alnylam Pharmaceuticals, Inc. (DUL.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
138.80+2.15 (+1.57%)
At close: 08:20AM CEST
Currency in EUR
Earnings EstimateCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
No. of Analysts17171919
Avg. Estimate-1.57-1.59-6.35-3.76
Low Estimate-2.01-2.49-7.82-6.65
High Estimate-1.25-0.84-5.16-0.43
Year Ago EPS-2.18-2.09-7.46-6.35
Revenue EstimateCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
No. of Analysts16162019
Avg. Estimate219.69M239.91M854.26M1.31B
Low Estimate211.2M214.4M823.6M1.1B
High Estimate240.1M263.8M902M1.6B
Year Ago Sales125.85M163.56M492.85M854.26M
Sales Growth (year/est)74.60%46.70%73.30%53.60%
Earnings History2020-09-302020-12-312021-03-312021-06-30
EPS Est.-1.64-1.71-1.73-1.61
EPS Actual-2.18-2.09-1.71-1.61
Difference-0.54-0.380.020
Surprise %-32.90%-22.20%1.20%0.00%
EPS TrendCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
Current Estimate-1.57-1.59-6.35-3.76
7 Days Ago-1.57-1.59-6.35-3.76
30 Days Ago-1.57-1.59-6.4-3.8
60 Days Ago-1.57-1.46-6.39-3.67
90 Days Ago-1.57-1.45-6.37-3.73
EPS RevisionsCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/A1N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesDUL.FIndustrySector(s)S&P 500
Current Qtr.28.00%N/AN/AN/A
Next Qtr.23.90%N/AN/AN/A
Current Year14.90%N/AN/AN/A
Next Year40.80%N/AN/AN/A
Next 5 Years (per annum)7.86%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A